Resorcin Brown

Resorcin Brown

SCHEMBL110506

Cc1ccc(/N=N/c2c(O)ccc(/N=N/c3ccc(S(=O)(=O)O)cc3)c2O)c(C)c1

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RPS6KA3 P51812 1/20 0.59
ALDH1A1 P00352 2/20 0.57
HIF1A Q16665 2/20 0.57
CYP1A2 P05177 1/20 0.57
CYP2C9 P11712 1/20 0.57
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
MAPT P10636 2/20 0.50
MAPK1 P28482 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
ENPP2 Q13822 1/20 0.49
THRB P10828 2/20 0.49
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
GAA P10253 1/20 0.47
PHLPP2 Q6ZVD8 4/20 0.47
ATIC P31939 1/20 0.46
GLO1 Q04760 1/20 0.46
CYP3A4 P08684 1/20 0.45
ALOX15 P16050 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Resorcin Brown SCHEMBL110507 1.00 RPS6KA3 (0.59) RPS6KA3ALDH1A1HIF1ACYP1A2CYP2C9
Resorcin Brown SCHEMBL31650975 1.00 RPS6KA3 (0.59) RPS6KA3ALDH1A1HIF1ACYP1A2CYP2C9
Resorcin Brown SCHEMBL185546 0.99 RPS6KA3 (0.57) RPS6KA3ALDH1A1HIF1ACYP1A2CYP2C9
Resorcin Brown SCHEMBL185544 0.99 RPS6KA3 (0.57) RPS6KA3ALDH1A1HIF1ACYP1A2CYP2C9
Resorcin Brown SCHEMBL185545 0.89 THRB (0.53) RPS6KA3ALDH1A1HIF1ACYP1A2CYP2C9
Resorcin Brown SCHEMBL109260 0.89 THRB (0.53) RPS6KA3ALDH1A1HIF1ACYP1A2CYP2C9
SCHEMBL8946891 0.87 NPC1 (0.61) ALDH1A1HIF1ACYP1A2CYP2C9NPC1
SCHEMBL5351766 0.86 RPS6KA3 (0.59) RPS6KA3ALDH1A1HIF1ACYP1A2CYP2C9
SCHEMBL19958473 0.84 NPC1 (0.69) ALDH1A1HIF1ACYP1A2NPC1RAB9A
SCHEMBL1567479 0.83 FTO (0.61) ALDH1A1HIF1ANPC1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2424491-B1 FILM FORMER IN HAIR COLOURS HENKEL AG & CO KGAA (DE) 2017-05-24 EP disclosed
US-9504637-B2 Coloring agents and methods of use thereof LIVING PROOF, INC. (US) 2016-11-29 US disclosed
US-20160106648-A1 COLORING AGENTS AND METHODS OF USE THEREOF LIVING PROOF, INC. (US) 2016-04-21 US disclosed
US-9248086-B2 Coloring agents and methods of use thereof LIVING PROOF, INC. (US) 2016-02-02 US disclosed
US-20150174026-A1 COLORING AGENTS AND METHODS OF USE THEREOF LIVING PROOF, INC. 2015-06-25 US disclosed
US-8932370-B2 Coloring agents and methods of use thereof LIVING PROOF, INC. (US) 2015-01-13 US disclosed
US-20140326269-A1 COLORING AGENTS AND METHODS OF USE THEREOF LIVING PROOF, INC. 2014-11-06 US disclosed
US-8758451-B2 Coloring agents and methods of use thereof LIVING PROOF, INC. (US) 2014-06-24 US disclosed
US-20140013520-A1 COLORING AGENTS AND METHODS OF USE THEREOF LIVING PROOF, INC. 2014-01-16 US disclosed
US-20120272990-A1 COLORING AGENTS AND METHODS OF USE THEREOF LIVING PROOF, INC. (US) 2012-11-01 US disclosed
US-8187340-B2 Coloring agents and methods of use thereof LIVING PROOF, INC. (US) 2012-05-29 US disclosed
EP-2424491-A2 FILM FORMER IN HAIR DYES Henkel AG & Co. KGaA (DE) 2012-03-07 EP disclosed
WO-2011084803-A2 COLORING AGENTS AND METHODS OF USE THEREOF LIVING PROOF, INC. (US) 2011-07-14 WO disclosed
US-20110154583-A1 COLORING AGENTS AND METHODS OF USE THEREOF LIVING PROOF, INC. (US) 2011-06-30 US disclosed
WO-2010124897-A2 FILM FORMER IN HAIR DYES HENKEL AG & CO. KGAA (DE) 2010-11-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120272990-A1 COLORING AGENTS AND METHODS OF USE THEREOF MPO, HLA-C, ADH7 RPS6KA3 4726/4885ALDH1A1 192/4885HIF1A 891/4885
US-20110154583-A1 COLORING AGENTS AND METHODS OF USE THEREOF MPO, HLA-C, ADH7 RPS6KA3 4726/4885ALDH1A1 192/4885HIF1A 891/4885
US-20160106648-A1 COLORING AGENTS AND METHODS OF USE THEREOF MPO, HLA-C, ADH7 RPS6KA3 4726/4885ALDH1A1 192/4885HIF1A 891/4885
US-20140013520-A1 COLORING AGENTS AND METHODS OF USE THEREOF MPO, HLA-C, ADH7 RPS6KA3 4726/4885ALDH1A1 192/4885HIF1A 891/4885
US-20150174026-A1 COLORING AGENTS AND METHODS OF USE THEREOF MPO, HLA-C, ADH7 RPS6KA3 4726/4885ALDH1A1 192/4885HIF1A 891/4885
US-20140326269-A1 COLORING AGENTS AND METHODS OF USE THEREOF MPO, HLA-C, ADH7 RPS6KA3 4726/4885ALDH1A1 192/4885HIF1A 891/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.